Views: 0 Author: Site Editor Publish Time: 2021-04-13 Origin: Site
The global nucleic acid isolation and purification market size was valued at USD 4.1 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.4% from 2021 to 2028. Key drivers contributing to the market growth are the rise in adoption of sequencing platforms in clinical diagnostics, growth in genomics and enzymology-based research, and increasing investments in R&D pertaining to molecular biology and precision medicine.
The growing collaborations between different companies and organizations in the biotech industry is one of the factors driving the market.
The development of personalized medicine is another important factor that drives revenue generation in the market for nucleic acid isolation and purification. Next Generation Sequencing (NGS) is becoming increasingly popular in cancer tumor biopsies. Liquid biopsies are an attractive option for cancer diagnostics because the process employs a simple and routine test that can detect cancer at an early stage.
Early diagnosis of cancer is the biggest challenge, and NGS can help effectively tackle the problem, increasing the demand for NGS technology. Therefore, an increase in the use of NGS technology is anticipated to directly impact the adoption of nucleic acid isolation and purification techniques.
Formalin-Fixed Paraffin-Embedded (FFPE) samples that are considered important in determining molecular correlates of carcinogenesis require labor-intensive nucleic acid purification for the sample, and such protocols also damage the nucleic acids. To combat such challenges companies are launching new extraction kits for efficient recovery of nucleic acids.